CHICAGO TRUST Co NA Sells 4,818 Shares of Zoetis Inc. $ZTS

CHICAGO TRUST Co NA decreased its stake in shares of Zoetis Inc. (NYSE:ZTS) by 43.8% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 6,176 shares of the company’s stock after selling 4,818 shares during the quarter. CHICAGO TRUST Co NA’s holdings in Zoetis were worth $904,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of ZTS. Scott & Selber Inc. grew its position in shares of Zoetis by 0.6% during the second quarter. Scott & Selber Inc. now owns 11,652 shares of the company’s stock valued at $1,817,000 after purchasing an additional 67 shares in the last quarter. North Star Asset Management Inc. grew its holdings in Zoetis by 4.9% during the 2nd quarter. North Star Asset Management Inc. now owns 1,441 shares of the company’s stock valued at $225,000 after buying an additional 67 shares in the last quarter. Secure Asset Management LLC increased its stake in Zoetis by 2.9% in the 2nd quarter. Secure Asset Management LLC now owns 2,448 shares of the company’s stock worth $382,000 after acquiring an additional 68 shares during the last quarter. Moment Partners LLC raised its holdings in shares of Zoetis by 3.2% during the 2nd quarter. Moment Partners LLC now owns 2,354 shares of the company’s stock worth $367,000 after acquiring an additional 72 shares in the last quarter. Finally, CVA Family Office LLC raised its holdings in shares of Zoetis by 6.7% during the 2nd quarter. CVA Family Office LLC now owns 1,173 shares of the company’s stock worth $183,000 after acquiring an additional 74 shares in the last quarter. 92.80% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on ZTS. Weiss Ratings reissued a “hold (c-)” rating on shares of Zoetis in a report on Wednesday, October 8th. Morgan Stanley set a $160.00 target price on shares of Zoetis in a report on Thursday. Barclays began coverage on shares of Zoetis in a research report on Monday, December 8th. They set an “equal weight” rating and a $136.00 target price on the stock. Argus reissued a “buy” rating and set a $190.00 price objective on shares of Zoetis in a research note on Tuesday, September 9th. Finally, HSBC set a $140.00 price objective on Zoetis in a research note on Wednesday, December 10th. Six analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat, Zoetis presently has an average rating of “Hold” and an average target price of $160.18.

Zoetis Stock Performance

Zoetis stock opened at $122.34 on Friday. The company has a debt-to-equity ratio of 1.31, a current ratio of 3.64 and a quick ratio of 2.28. The firm has a market capitalization of $53.91 billion, a P/E ratio of 20.60, a price-to-earnings-growth ratio of 2.66 and a beta of 0.97. Zoetis Inc. has a 1-year low of $115.25 and a 1-year high of $177.40. The company’s 50-day moving average is $128.86 and its 200 day moving average is $144.48.

Zoetis (NYSE:ZTS) last released its earnings results on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.08. Zoetis had a return on equity of 57.19% and a net margin of 28.21%.The firm had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.42 billion. During the same quarter in the prior year, the firm posted $1.58 earnings per share. The company’s quarterly revenue was up .5% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Research analysts forecast that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 3rd. Stockholders of record on Tuesday, January 20th will be given a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a dividend yield of 1.7%. This is a positive change from Zoetis’s previous quarterly dividend of $0.50. The ex-dividend date is Tuesday, January 20th. Zoetis’s dividend payout ratio is 33.67%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.